BioCentury
ARTICLE | Clinical News

SURVEYOR Scan K-RAS kit regulatory update

May 28, 2012 7:00 AM UTC

Transgenomic said it received CE Mark approval for its SURVEYOR Scan K-RAS Kit to detect mutations in K-RAS associated with drug-resistant tumors. The kit is used exclusively with the company's WAVE M...